Vaso Intestinal Peptid (VIP) RIA

pVaso Intestinal Peptid (VIP) br /
RIAbr /
img alt=For Research Use Only src=http://www.alpco.com/img/ruo.gif align=absMiddle / For Research Use Only/p
div class=prod_head_infohr /
/div
div class=prod_spec_box
div class=prod_specFormat:/div
div class=prod_spec_infoRadioimmunoassay/div
/div
div class=prod_spec_box
div class=prod_specSample Type:/div
div class=prod_spec_infoSerum/div
/div
div class=prod_spec_box
div class=prod_specbSample Size:/b/div
div class=prod_spec_info200 micro;l/div
/div
div class=prod_spec_box
div class=prod_specbSize:/b/div
div class=prod_spec_info100 Tubes/div
/div
div class=prod_spec_box
div class=prod_specbRange:/b/div
div class=prod_spec_info3.8 - 120 pmol/l/div
/div
div class=prod_spec_box
div class=prod_specbSensitivity:/b/div
div class=prod_spec_info3 pmol/l/div
/div
div class=prod_spec_box
div class=prod_specbIncubation Time:/b/div
div class=prod_spec_infoOvernight/div
div class=prod_spec_info
pbSummary:/b/p
Vaso Intestinal Peptid (VIP) RIA - VIP stimulates water and bicarbonate secretion by the pancreas. VIP possesses the capacity to relax smooth muscle. Administration of VIP produces vasodilation and pulmonary broncho- dilation and relaxes the lower eosophagaeal sphincter and smooth muscle of the fundus of the stomach. VIP is believed to play crucial roles in the regulation of intestinal motility and intestinal epithelial ion and water transport. Increased plasma immunoreactive VIP concentrations have been reported in patients with the WDHA syndrome (water, diarrhoea, hypokalemia and achlor hydria). Increased plasma levels of VIP have also been reported in patients with cirrhosis./div
/div